CoChat

Total Synthesis and Biological Mode of Action of Largazole: A Potent Class I Histone Deacetylase Inhibitor

Open access

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Abstract

The efficient total synthesis of the recently described natural substance largazole (1) and its active metabolite largazole thiol (2) is described. The synthesis required eight linear steps and proceeded in 37% overall yield. It is demonstrated that largazole is a pro-drug that is activated by removal of the octanoyl residue from the 3-hydroxy-7-mercaptohept-4-enoic acid moiety to generate the active metabolite 2, which is an extraordinarily potent Class I histone deacetylase inhibitor. Synthetic largazole and 2 have been evaluated side-by-side with FK228 and SAHA for inhibition of HDACs 1, 2, 3, and 6. Largazole and largazole thiol were further assayed for cytotoxic activity against a panel of chemoresistant melanoma cell lines, and it was found that largazole is substantially more cytotoxic than largazole thiol; this difference is attributed to differences in the cell permeability of the two substances.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/ja8033763

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 3

  1. Townsend P. A., 2007, Chemical Biology, 69, 3
  2. Yurek-George A., 2004, J. Am. Chem. Soc., 126, 1030, 10.1021/ja039258q · DOI
  3. Furumai R., 2002, Cancer Res., 62, 4916

Cited by

Metadata

Authors
Bowers, A., West, N., Taunton, J., Schreiber, S. L., Bradner, J. E., & Williams, R. M.
Affiliations
Broad Institute (US)
Venue
Journal of the American Chemical Society
Published
2008-07-19
Volume
130
Issue
33
Pages
11219-11222
ISSN
  • 0002-7863 (ISSN-L)
  • 1520-5126
OpenAlex
W2082971158
Cited by
165
References
33
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 8 · 2022: 3 · 2021: 10 · 2020: 3 · 2019: 9 · 2018: 6 · 2017: 12 · 2016: 9 · 2015: 12 · 2014: 13 · 2013: 10 · 2012: 10
FWCI
7.82
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Chemical Society (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Wellcome Trust
  • National Institutes of Health (1p41gm049631-01, n01co12400-79-0-22)
  • National Cancer Institute (N01CO12400, N01-CO-012400, K08CA128972, R01CA152314)
  • National Institute of General Medical Sciences (GM49631)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
  • Physical Sciences › Chemistry › Organic Chemistry › Isoquinoline Alkaloid Synthesis
Keywords
largazole, total synthesis, prodrugs, class I histone deacetylase inhibitors, romidepsin, vorinostat, HDAC1, HDAC2, HDAC3, HDAC6, cytotoxicity, membrane permeability
MeSH terms
Vorinostat, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Enzyme Inhibitors, Humans, Hydroxamic Acids, Molecular Conformation, Stereoisomerism, Structure-Activity Relationship, Sulfhydryl Compounds, Thiazoles, Cell Line, Tumor, Depsipeptides, Cell Proliferation, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.